However, recent in vitro and in vivo studies have shown that RON expression or activation is altered in epithelial carcinomas including lung, colon, and breast cancers [6, 11–15], indicating that abnormal activation of this receptor may play a role in the progression of certain epithelial cancers. The gene discussed is MST1R; the disease is breast carcinoma.